| Title | Author(s) | Issue date | ???itemlist.??? |
| Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG) | Kosmidis, P.; Mylonakis, N.; Skarlos, D.; Samantas, E.; Dimopoulos, M.; Papadimitriou, C.; Kalophonos, C.; Pavlidis, N.; Nikolaidis, C.; Papaconstantinou, C.; Fountzilas, G. | 24-Nov-2015 | - |
| Paclitaxel (175 mg/m2) plus carboplatin versus paclitaxel (225 mg/m2) plus carboplatin in non-small cell lung cancer: a randomized study | Kosmidis, P.; Mylonakis, N.; Fountzilas, G.; Samantas, E.; Athanassiadis, A.; Pavlidis, N.; Skarlos, D. | 24-Nov-2015 | - |
| Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology Group | Fountzilas, G.; Pectasides, D.; Kalogera-Fountzila, A.; Skarlos, D.; Kalofonos, H. P.; Papadimitriou, C.; Bafaloukos, D.; Lambropoulos, S.; Papadopoulos, S.; Kourea, H.; Markopoulos, C.; Linardou, H.; Mavroudis, D.; Briasoulis, E.; Pavlidis, N.; Razis, E.; Kosmidis, P.; Gogas, H. | 24-Nov-2015 | - |
| Paclitaxel and carboplatin in inoperable non-small-cell lung cancer: a phase II study | Kosmidis, P. A.; Mylonakis, N.; Fountzilas, G.; Samantas, E.; Athanasiadis, A.; Andreopoulou, E.; Pavlidis, N.; Skarlos, D. | 24-Nov-2015 | - |
| Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology Group | Fountzilas, G.; Kalofonos, H. P.; Dafni, U.; Papadimitriou, C.; Bafaloukos, D.; Papakostas, P.; Kalogera-Fountzila, A.; Gogas, H.; Aravantinos, G.; Moulopoulos, L. A.; Economopoulos, T.; Pectasides, D.; Maniadakis, N.; Siafaka, V.; Briasoulis, E.; Christodoulou, C.; Tsavdaridis, D.; Makrantonakis, P.; Razis, E.; Kosmidis, P.; Skarlos, D.; Dimopoulos, M. A. | 24-Nov-2015 | - |
| Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG) | Kosmidis, P. A.; Fountzilas, G.; Eleftheraki, A. G.; Kalofonos, H. P.; Pentheroudakis, G.; Skarlos, D.; Dimopoulos, M. A.; Bafaloukos, D.; Pectasides, D.; Samantas, E.; Boukovinas, J.; Lambaki, S.; Katirtzoglou, N.; Bakogiannis, C.; Syrigos, K. N. | 24-Nov-2015 | - |
| Paclitaxel by 3-h infusion and carboplatin in anthracycline-resistant advanced breast cancer. A phase II study conducted by the Hellenic Cooperative Oncology Group | Fountzilas, G.; Athanassiadis, A.; Kalogera-Fountzila, A.; Aravantinos, G.; Bafaloukos, D.; Briasoulis, E.; Dombros, N.; Ioannidis, I.; Pavlidis, N.; Kosmidis, P.; Skarlos, D. | 24-Nov-2015 | - |
| Paclitaxel by three-hour infusion and carboplatin in advanced carcinoma of nasopharynx and other sites of the head and neck. A phase II study conducted by the Hellenic Cooperative Oncology Group | Fountzilas, G.; Skarlos, D.; Athanassiades, A.; Kalogera-Fountzila, A.; Samantas, E.; Bacoyiannis, C.; Nicolaou, A.; Dombros, N.; Briasoulis, E.; Dinopoulou, M.; Stathopoulos, G.; Pavlidis, N.; Kosmidis, P.; Daniilidis, J. | 24-Nov-2015 | - |
| Paclitaxel in combination with carboplatin or gemcitabine for the treatment of advanced head and neck cancer | Fountzilas, G.; Athanassiades, A.; Kalogera-Fountzila, A.; Samantas, E.; Bacoyiannis, C.; Briassoulis, E.; Pavlidis, N.; Kosmidis, P.; Skarlos, D. | 24-Nov-2015 | - |
| Paclitaxel, cisplatin, leucovorin, and continuous infusion fluorouracil followed by concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the head and neck - A Hellenic cooperative oncology group phase II study | Fountzilas, G.; Tolis, C.; Kalogera-Fountzila, A.; Misailidou, D.; Tsekeris, P.; Karina, M.; Nikolaou, A.; Samantas, E.; Makatsoris, T.; Athanassiou, E.; Skarlos, D.; Bamias, A.; Zamboglou, N.; Economopoulos, T.; Karanastassi, S.; Pavlidis, N.; Daniilidis, J. | 24-Nov-2015 | - |
| Paclitaxel, cisplatin, leucovorin, and continuous infusion fluorouracil followed by concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the head and neck: a Hellenic Cooperative Oncology Group Phase II Study | Fountzilas, G.; Tolis, C.; Kalogera-Fountzila, A.; Misailidou, D.; Tsekeris, P.; Karina, M.; Nikolaou, A.; Samantas, E.; Makatsoris, T.; Athanassiou, E.; Skarlos, D.; Bamias, A.; Zamboglou, N.; Economopoulos, T.; Karanastassi, S.; Pavlidis, N.; Daniilidis, J. | 24-Nov-2015 | - |
| Personality factors associated with psychological distress in testicular cancer survivors | Siafaka, V.; Hyphantis, T. N.; Alamanos, I.; Fountzilas, G.; Skarlos, D.; Pectasides, D.; Mavreas, V.; Pavlidis, N. | 24-Nov-2015 | - |
| Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancer | Briasoulis, E.; Samantas, E.; Kalofonos, H.; Skarlos, D.; Makatsoris, T.; Christodoulou, C.; Fountzilas, G.; Bamias, A.; Dimopoulos, M. A.; Kosmidis, P.; Pavlidis, N. | 24-Nov-2015 | - |
| Phase II study of 5-fluorouracil and interferon-gamma in patients with metastatic colorectal cancer. A Hellenic Cooperative Oncology Group Study | Pavlidis, N.; Nicolaides, C.; Athanassiadis, A.; Beriatou, K.; Skarlos, D.; Giannakakis, T.; Kosmidis, P.; Karvounis, N.; Fountzilas, G. | 24-Nov-2015 | - |
| Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group | Fountzilas, G.; Skarlos, D.; Dafni, U.; Gogas, H.; Briasoulis, E.; Pectasides, D.; Papadimitriou, C.; Markopoulos, C.; Polychronis, A.; Kalofonos, H. P.; Siafaka, V.; Kosmidis, P.; Timotheadou, E.; Tsavdaridis, D.; Bafaloukos, D.; Papakostas, P.; Razis, E.; Makrantonakis, P.; Aravantinos, G.; Christodoulou, C.; Dimopoulos, A. M. | 24-Nov-2015 | - |
| Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00 | Fountzilas, G.; Dafni, U.; Gogas, H.; Linardou, H.; Kalofonos, H. P.; Briasoulis, E.; Pectasides, D.; Samantas, E.; Bafaloukos, D.; Stathopoulos, G. P.; Karina, M.; Papadimitriou, C.; Skarlos, D.; Pisanidis, N.; Papakostas, P.; Markopoulos, C.; Tzorakoeleftherakis, E.; Dimitrakakis, K.; Makrantonakis, P.; Xiros, N.; Polichronis, A.; Varthalitis, I.; Karanikiotis, C.; Dimopoulos, A. M. | 24-Nov-2015 | - |
| Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group | Fountzilas, G.; Zisiadis, A.; Dafni, U.; Konstantaras, C.; Hatzitheoharis, G.; Liaros, A.; Athanassiou, E.; Dombros, N.; Dervenis, C.; Basdanis, G.; Gamvros, O.; Souparis, A.; Briasoulis, E.; Samantas, E.; Kappas, A.; Kosmidis, P.; Skarlos, D.; Pavlidis, N. | 24-Nov-2015 | - |
| Prognostic factors influencing complete response to treatment and survival of patients with nasopharyngeal cancer | Kalogera-Fountzila, A.; Kosmidis, P.; Bacoyiannis, C.; Nicolaou, A.; Samantas, E.; Briassoulis, E.; Pavlidis, N.; Skarlos, D.; Daniilidis, J.; Fountzilas, G. | 24-Nov-2015 | - |
| Prognostic variable in patients with advanced colorectal cancer treated with fluorouracil and leucovorin-based chemotherapy | Fountzilas, G.; Gossios, K.; Zisiadis, A.; Svarna, E.; Skarlos, D.; Pavlidis, N. | 24-Nov-2015 | - |
| A prospective randomized phase III study in non-small-cell lung cancer comparing cisplatin, ifosfamide, vinblastine (VIP) versus cisplatin, ifosfamide and etoposide (VIP-16). Hellenic Co-Operative Oncology Group | Kosmidis, P.; Mylonakis, N.; Fountzilas, G.; Pavlidis, N.; Samantas, E.; Karabelis, A.; Kattis, K.; Skarlos, D. | 24-Nov-2015 | - |
